| Alberta Gene Therapy Group |
|
A group of gene therapy researchers interested in research in the field of gene therapy.
Submitted: Oct 25, 2000
|
| AMT |
|
Developes gene therapies for lipoprotein lipase disorder, inflammatory bowel disease and neuroregeneration. Provides contract development and manufacturing of gene and cell-based products.
Submitted: Oct 26, 2000
|
| BioVex |
|
BioVex’s gene delivery technology allows pharmaceutical and genomics companies to assess the therapeutic value of identified genes. The company’s technology also allows genes to be used as therapeutic products to treat diseases from cancer to nervous and immune system disorders.
Submitted: Oct 26, 2000
|
| Cell Genesys |
|
Cell Genesys is focused on the development and commercialization of cancer vaccines and gene therapies to treat major, life-threatening diseases.
Submitted: Oct 25, 2000
|
| Collateral Therapeutics |
|
Collateral Therapeutics (CLTX) is focused on the discovery, development and commercialization of non-surgical gene therapy products for the treatment of cardiovascular diseases, including coronary artery disease, peripheral vascular disease, congestive heart failure and heart attack.
Submitted: Oct 26, 2000
|
| Gene Therapy Systems |
|
Gene Therapy Systems, Inc. (GTS) headquartered in San Diego, California, designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research.
Submitted: Oct 25, 2000
|
| Genteric Inc. |
|
Genteric, Inc. is a biotech company formed in 1997 to commercialize revolutionary gene delivery platforms and create new and improved protein drug therapies. Genteric's innovative systems enable a patient's gastrointestinal system to produce and secrete therapeutic proteins into the bloodstream.
Submitted: Oct 26, 2000
|
| Molecular Medicine: Gene Therapy |
|
Molecular Medicine, based in San Diego, is a development and manufacturing company dedicated to the production of high-quality, clinical grade, gene and cell based therapeutics and reagents.
Submitted: Oct 25, 2000
|
| Pittsburgh Human Gene Therapy Center |
|
The mission of the The Pittsburgh Human Gene Therapy Center is to foster the growth and development of multidisciplinary preclinical and clinical research programs aimed at the use of gene transfer technologies for the treatment of human disease.
Submitted: Oct 25, 2000
|
| Puresyn |
|
Puresyn, Inc. is a Separations Technology Company that develops, manufactures and markets state-of-the-art products and services for the separation and purification of nucleic acids and other biological molecules utilizing its proprietary polymer technology, PolyFlo®. The Company markets and sells bioseparation large-scale systems, columns and chromatography media to leading drug and biotechnology companies to purify biopharmaceuticals.
Submitted: Oct 26, 2000
|
| Transgene |
|
Transgene is a biopharmaceutical company dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited diseases for which there is no cure or adequate therapy at present.
Submitted: Oct 25, 2000
|
| University of Texas M. D. Anderson Cancer Center Gene Therapy Department |
|
The human cancer gene prevention and therapy program conducts basic research, clinical trials and vector development.
Submitted: Oct 26, 2000
|
| Virapur |
|
Virapur sells virus purification kits for gene therapy and virus research. No cesium gradients. Easy for the non-virologist.
Submitted: Oct 26, 2000
|
|
